PLC Systems Discusses Benefits of CO2 TMR Therapy on CEOcast.com

PLC Systems Discusses Benefits of CO2 TMR Therapy on CEOcast.com 


FRANKLIN, Mass., Oct. 30  /PRNewswire-FirstCall/ -- PLC Systems Inc. , the
leader in carbon dioxide (CO2) TransMyocardial Revascularization (TMR) laser
technology used to treat patients with severe angina, or heart pain, today
announced that its President and Chief Executive Officer, Mark Tauscher, was
interviewed by CEOcast.com on Wednesday, October 29, 2003.

To listen to the interview, visit http://www.ceocast.com/.  During the
interview, PLC discusses the benefits the CO2 TMR angina relief therapy and
reviews its third quarter financial results.  PLC's third quarter results
represent the sixth consecutive profitable quarter for the Company.

PLC Systems Inc. is a medical device company specializing in the design and
manufacturing of carbon dioxide (CO2) lasers and related disposable components
to treat coronary artery disease.  Edwards Lifesciences Corporation (NYSE:EW) is
the exclusive U.S. marketer and distributor of PLC's CO2 Heart Laser 2 system,
which a cardiac surgeon can utilize to perform CO2 transmyocardial
revascularization (TMR).  CO2 TMR, pioneered by PLC Systems, is a surgical
technology for treating severe angina, or heart pain.  The CO2 Heart Laser is
the only revascularization laser that has published data showing long-term
(five-year) angina relief in severely debilitated heart patients.  For more
information on PLC and its products, please visit the Company's Web site at
http://www.plcmed.com/.

CEOcast is the premier source of premier source of original and syndicated
streaming broadcast interviews of Chief Executive Officers at public and private
news-making companies. Organized by industry, its analysts average over 15 years
experience covering and evaluating Wall Street's leading companies.

CEOcast's programming is distributed to millions of on-line investors at over
700 financial web sites as well as to more than 20,000 portfolio managers,
buy-side analysts and traders at more than 3,300 North American institutions.
Content is also disseminated to over 7,000 investment research professionals
representing over 425 institutions. All content is copyrighted to protect our
licensing partners.

  Contact:
   John Jordan
   Director of Investor Relations
   508-541-8800, ext. 145


DATASOURCE: PLC Systems Inc.



CONTACT:  John Jordan, Director of Investor Relations, PLC Systems Inc.,

[phone], ext. 145 



Web site:  http://www.plcmed.com/

Copyright